The metabolic alterations associated with obesity, including changes in insulin and insulin-like growth factor binding protein 1 (IGFBP-1) serum levels (which result in increased circulating free IGF-1 levels), are also significantly correlated with breast cancer recurrence and mortality [29]. Here, IGFBP1 is linked to obesity due to melanocortin 4 receptor deficiency.